Ultragenyx Pharmaceutical, Inc. (RARE)
23.88
-0.82
(-3.32%)
USD |
NASDAQ |
Feb 09, 16:00
23.80
-0.08
(-0.34%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Liabilities (Quarterly) : 1.174B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 191.70M |
| Johnson & Johnson | -- |
| CorMedix, Inc. | 376.73M |
| Insmed, Inc. | 1.415B |
| Apellis Pharmaceuticals, Inc. | 657.56M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.190B |
| Shareholders Equity (Quarterly) | 9.159M |
| Debt to Equity Ratio | 94.24 |
| Current Ratio | 1.892 |
| Net Debt Paydown Yield | 0.44% |